New hip resurfacing device tracked for 10 years
NCT ID NCT06775704
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 27 times
Summary
This study follows 150 people aged 18 to 65 who receive a ROMAX hip resurfacing implant to treat hip arthritis or congenital hip dysplasia. Researchers will monitor how long the implant lasts and measure hip function and patient satisfaction over 10 years. The goal is to confirm the device is safe and works well.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS HIP are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire de Lille
RECRUITINGLille, 59000, France
Conditions
Explore the condition pages connected to this study.